Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: February 26, 2026
Context: This filing serves as a Regulation FD disclosure to announce upcoming investor and analyst presentations. The company intends to utilize the material contained in Exhibit 99.1 (Investor Presentation dated February 2026) during these events.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding the distribution of an investor presentation rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported within the text of this filing. The document solely references the existence of an investor presentation to be used in future communications.
Guidance, Outlook, and Risks
Management Commentary: Executive officers have scheduled upcoming presentations for investors and analysts.
Legal Status of Information: The information in this Item 7.01 and the referenced Exhibit 99.1 is furnished pursuant to Regulation FD and is not deemed "filed" under Section 18 of the Exchange Act. It will not be incorporated by reference into other filings unless expressly stated.
Risks/Contingencies: No specific risks or contingencies are detailed in this filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated February 2026) for actual financial data and strategic outlook.
- Confirm the dates and times of the upcoming investor presentations mentioned by executive officers.
- Verify that the information in the investor presentation is not automatically incorporated into other SEC filings without specific reference.